Eli Lilly
1,211 hedge funds and large institutions have $61.1B invested in Eli Lilly in 2016 Q4 according to their latest regulatory filings, with 154 funds opening new positions, 424 increasing their positions, 442 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 424 | Existing positions reduced: 442
8% less capital invested
Capital invested by funds: $66.5B → $61.1B (-$5.36B)
28% less funds holding in top 10
Funds holding in top 10: 36 → 26 (-10)
Holders
1,211
Holding in Top 10
26
Calls
$1.47B
Puts
$927M
Top Buyers
| 1 | +$868M | |
| 2 | +$305M | |
| 3 | +$161M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$145M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$115M |
Top Sellers
| 1 | -$489M | |
| 2 | -$457M | |
| 3 | -$408M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$387M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$251M |